Clinical Laboratory Improvement Advisory Committee (CLIAC); Cancellation of Meeting, 16945 [2020-06249]
Download as PDF
<![CDATA[
16945
Federal Register / Vol. 85, No. 58 / Wednesday, March 25, 2020 / Notices
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
interviews *
Form name
Average
hourly wage
rate **
Total burden
hours
Total cost
burden
PC CDS Learning Network—Leader ...............................................................
PC CDS Learning Network—Governance/Non-Executive Steering Committee ............................................................................................................
PC CDS Learning Network—Contributor ........................................................
CDS Connect—Leader ....................................................................................
CDS Connect—Contributor .............................................................................
CDS Connect—Consumer ...............................................................................
CDS Connect—Participant ..............................................................................
Quantifying Efficiencies—Leader .....................................................................
Quantifying Efficiencies—Informaticist .............................................................
Quantifying Efficiencies—Clinician ..................................................................
PC CDS Projects –Site Leader .......................................................................
PC CDS Projects—Informaticist ......................................................................
PC CDS Projects—Clinician ............................................................................
PC CDS Projects—Patient ..............................................................................
Web Survey of CDS Connect Users ...............................................................
7
7
1 $59.54
$416.78
3
8
5
20
25
10
5
4
8
18
10
20
4
453
3
8
5
20
25
10
5
4
8
18
10
20
4
77
1 59.54
2 59.54
178.62
476.33
297.71
1,190.82
1,488.53
595.41
297.71
238.16
811.46
1,071.74
595.40
2,028.60
99.93
4,584.66
Total ..........................................................................................................
600
224
........................
14,371.85
1 59.54
1 59.54
1 59.54
1 59.54
1 59.54
1 59.54
1 59.54
1 101.43
1 59.54
1 59.54
2 101.43
1 24.98
** Wage rates were calculated using the mean hourly wage from the U.S. Department of Labor, Bureau of Labor Statistics, May 2018 National
Occupational Employment and Wage Estimates for the United States, https://www.bls.gov/oes/current/oes_nat.htm.
1 Average rate for Computer Information and Research Scientists.
2 Average rate for Physicians and Surgeons.
3 Average rate for All Occupations.
Request for Comments
khammond on DSKJM1Z7X2PROD with NOTICES
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ’s health care
research and health care information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: March 19, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020–06208 Filed 3–24–20; 8:45 am]
BILLING CODE 4160–90–P
VerDate Sep<11>2014
16:18 Mar 24, 2020
Jkt 250001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Clinical Laboratory Improvement
Advisory Committee (CLIAC);
Cancellation of Meeting
Notice is hereby given of a change in
the meeting of the Clinical Laboratory
Improvement Advisory Committee
(CLIAC); April 16, 2020, 8:30 a.m. to
5:00 p.m., EDT and April 17, 2020, 8:30
a.m. to 11:30 a.m., EDT, in the original
FRN. Food and Drug Administration
(FDA), White Oak Campus, 10903 New
Hampshire Avenue, Building 31, Great
Room, Silver Spring, Maryland 20993
and via webcast at www.cdc.gov/cliac
which was published in the Federal
Register on February 28, 2020, Volume
85, Number 40, page 11993.
This meeting is being canceled in its
entirety.
FOR FURTHER INFORMATION CONTACT:
Nancy Anderson, MMSc, MT(ASCP),
Senior Advisor for Clinical Laboratories,
Division of Laboratory Systems, Center
for Surveillance, Epidemiology and
Laboratory Services, Office of Public
Health Scientific Services, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop V24–3,
Atlanta, Georgia 30329–4027, telephone
(404) 498–2741; NAnderson@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–06249 Filed 3–24–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC); Correction
Notice is hereby given of a change in
the meeting of the Board of Scientific
Counselors, National Center for Injury
Prevention and Control, (BSC, NCIPC);
April 30, 2020, 12:30 p.m. to 3:50 p.m.,
EDT which was published in the
Federal Register on February 24, 2020,
Volume 85, Number 36, pages 10441–
10442.
The SUMMARY should read as follows:
SUMMARY: In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC). This
E:\FR\FM\25MRN1.SGM
25MRN1
]]>Agencies
[Federal Register Volume 85, Number 58 (Wednesday, March 25, 2020)]
[Notices]
[Page 16945]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06249]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Clinical Laboratory Improvement Advisory Committee (CLIAC);
Cancellation of Meeting
Notice is hereby given of a change in the meeting of the Clinical
Laboratory Improvement Advisory Committee (CLIAC); April 16, 2020, 8:30
a.m. to 5:00 p.m., EDT and April 17, 2020, 8:30 a.m. to 11:30 a.m.,
EDT, in the original FRN. Food and Drug Administration (FDA), White Oak
Campus, 10903 New Hampshire Avenue, Building 31, Great Room, Silver
Spring, Maryland 20993 and via webcast at www.cdc.gov/cliac which was
published in the Federal Register on February 28, 2020, Volume 85,
Number 40, page 11993.
This meeting is being canceled in its entirety.
FOR FURTHER INFORMATION CONTACT: Nancy Anderson, MMSc, MT(ASCP), Senior
Advisor for Clinical Laboratories, Division of Laboratory Systems,
Center for Surveillance, Epidemiology and Laboratory Services, Office
of Public Health Scientific Services, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, Mailstop V24-3, Atlanta, Georgia
30329-4027, telephone (404) 498-2741; [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-06249 Filed 3-24-20; 8:45 am]
BILLING CODE 4163-18-P
